You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Patent: 5,409,990


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,409,990
Title: Complex containing coagulation factor IX
Abstract:Factor IX is selectively adsorbed by means of hydrophobic chromatography from an aqueous mixture containing at least one plasma zymogen or a vitamin-K dependent protein in addition to factor IX. By this method, the efficient enrichment of factor IX for the production of pharmaceutical preparations has become possible.
Inventor(s): Linnau; Yendra (Vienna, AT), Sazgary; Maria (Vienna, AT)
Assignee: Immuno Aktiengesellschaft (Wien, AT)
Application Number:08/146,921
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis Using United States Patent 5,409,990 as an Example

Introduction

Patents are a crucial component of intellectual property protection, allowing inventors and companies to safeguard their innovations and prevent unauthorized use. To fully comprehend the significance and implications of a patent, it is essential to delve into its scope and claims. This article will use United States Patent 5,409,990 as a case study to illustrate the key aspects of patent scope and claims, as well as the broader patent landscape.

What is a Patent?

A patent is a grant of rights given by a government to an inventor for a limited time in exchange for the public disclosure of an invention. In the United States, patents are issued by the U.S. Patent and Trademark Office (USPTO)[2].

The Patenting Process

Before a patent is granted, the invention must go through a rigorous process. This includes filing a provisional patent application, followed by a non-provisional patent application within one year. The USPTO then reviews the application to determine if the invention is novel, nonobvious, and enabled[2].

Patent Scope and Claims

The scope and claims of a patent are its most critical components.

Claim Scope

The claims of a patent define the boundaries of the invention and determine what is protected. A common misconception is that broader claims are always better, but this is not the case. Broader claims can be more difficult to get granted and are easier to invalidate. The claim scope must be anchored to the embodiments described in the specification to avoid issues like the abstract idea exception[3].

Example: United States Patent 5,409,990

To illustrate this, let's consider a hypothetical analysis of United States Patent 5,409,990, though the specific details of this patent are not provided here. Generally, the claims would be carefully crafted to ensure they are neither too broad nor too narrow.

  • Claim Construction: Each claim would be analyzed to ensure it meets the criteria of being novel, nonobvious, and enabled. The claim language would need to be precise and tied to the specific embodiments described in the patent specification.
  • Prior Art: The patent office would review prior art to ensure the claims do not overlap with existing inventions. This process is crucial in determining the validity and scope of the patent[2].

Patent Infringement and Litigation

Patent infringement occurs when someone makes, uses, sells, or imports an invention without the patent holder's permission. The landscape of patent litigation is complex and influenced by several factors.

Factors Influencing Patent Litigation

  • Legislative Changes: Changes in laws, such as the Leahy-Smith America Invents Act (AIA), can significantly impact patent litigation. For example, the AIA limited the number of defendants in a lawsuit, leading to an increase in the number of lawsuits filed[1].
  • Non-Practicing Entities (NPEs): Entities that own patents but do not make products can also influence patent litigation. These entities may file lawsuits to assert their patents for profit, which has raised concerns among legal commentators and technology companies[1].

The Role of the USPTO

The USPTO plays a critical role in maintaining the quality of patents and the patent examination process.

Linking Litigation Trends to Patent Examination

The USPTO has been recommended to examine trends in patent infringement litigation and link this information to internal data on patent examination. This can help improve the quality of issued patents by identifying patterns that may lead to litigation[1].

International Patent Landscape

The global patent system is increasingly interconnected.

Global Dossier and Common Citation Document

Tools like the Global Dossier and the Common Citation Document facilitate the integration of the global patent system. These tools provide access to file histories of related applications from participating IP offices and consolidate prior art citations, making it easier to navigate the international patent landscape[4].

Best Practices for Drafting Patent Claims

Drafting patent claims is a delicate process that requires careful consideration of several factors.

Avoiding Overly Broad Claims

Claims should not be overly broad, as this can lead to invalidation. For instance, claims that fall under the abstract idea exception, as seen in cases like Yu v. Apple Inc. and Minerva Surgical, Inc. v. Hologic, Inc., can be invalidated if they do not provide an inventive step that transforms the abstract idea into a patent-eligible invention[3][5].

Budget and Technical Field Considerations

The claim scope should also consider the client’s budget and the technical field. In fields with extensive prior art, broader claims are more challenging to get granted and may be more expensive to prosecute[3].

Key Takeaways

  • Precise Claim Construction: Ensure claims are precisely tied to the embodiments described in the patent specification.
  • Avoid Overly Broad Claims: Broad claims are more difficult to get granted and easier to invalidate.
  • Consider Prior Art: Thoroughly review prior art to ensure the claims do not overlap with existing inventions.
  • Legislative and Judicial Impacts: Changes in laws and judicial decisions can significantly impact patent litigation and the validity of patents.
  • International Integration: The global patent system is increasingly interconnected, with tools like the Global Dossier and Common Citation Document facilitating this integration.

FAQs

Q: What is the importance of claim scope in a patent application? A: The claim scope defines the boundaries of the invention and determines what is protected. It must be carefully crafted to avoid issues like invalidation due to overly broad claims.

Q: How do legislative changes affect patent litigation? A: Legislative changes, such as the Leahy-Smith America Invents Act, can influence the number of lawsuits filed and the way they are structured.

Q: What is the role of the USPTO in improving patent quality? A: The USPTO can improve patent quality by examining trends in patent infringement litigation and linking this information to internal data on patent examination.

Q: Why is it important to avoid overly broad claims in a patent application? A: Overly broad claims are more difficult to get granted and easier to invalidate, as they may fall under exceptions like the abstract idea exception.

Q: How does the global patent system facilitate international patent searches and filings? A: Tools like the Global Dossier and Common Citation Document provide access to file histories and consolidate prior art citations, making it easier to navigate the international patent landscape.

Sources

  1. GAO Report: Assessing Factors That Affect Patent Infringement Litigation[1].
  2. KU Office of Research: Intellectual Property Protection[2].
  3. Rimon Law: The Importance of Getting the Claim Scope Right in a US Patent Application[3].
  4. USPTO: Search for patents[4].
  5. CAFC Opinion: AI VISUALIZE, INC. v. NUANCE COMMUNICATIONS, INC.[5].

More… ↓

⤷  Subscribe

Details for Patent 5,409,990

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Grifols Biologicals Llc PROFILNINE, PROFILNINE HP, PROFILNINE HT, PROFILNINE SD factor ix complex For Injection 102476 July 20, 1981 ⤷  Subscribe 2012-04-25
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.